LEVALBUTEROL TARTRATE

LEVALBUTEROL TARTRATE was reported 3733 times

LEVALBUTEROL TARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 3 0.0357
1 DEVICE DELIVERY SYSTEM ISSUE 642 0.0234
2 ALLERGY TO VACCINE 7 0.0227
3 FACIAL OPERATION 3 0.0186
4 BULLOUS LUNG DISEASE 2 0.0159
5 ALLERGY TO PLANTS 6 0.0131
6 BLADDER OUTLET OBSTRUCTION 2 0.0121
7 VASCULAR ACCESS SITE COMPLICATION 3 0.0119
8 PRODUCT INEFFECTIVE 8 0.0102
9 CEREBRAL AMYLOID ANGIOPATHY 3 0.0091
10 INFUSION SITE DISCHARGE 15 0.0085
11 CHRONIC RESPIRATORY DISEASE 3 0.0085
12 INFUSION SITE URTICARIA 5 0.0075
13 CATHETERISATION CARDIAC ABNORMAL 2 0.0074
14 DEATH OF RELATIVE 3 0.0074
15 DRUG DOSE OMISSION BY DEVICE 556 0.0071
16 CHONDROMALACIA 2 0.0070
17 INFUSION SITE BRUISING 15 0.0069
18 HAEMANGIOMA OF SKIN 3 0.0069
19 OBSTRUCTIVE SLEEP APNOEA SYNDROME 10 0.0069
20 INFUSION SITE SCAR 3 0.0068
21 BRONCHOSPASM PARADOXICAL 2 0.0066
22 ESSENTIAL HYPERTENSION 12 0.0066
23 CENTRAL SLEEP APNOEA SYNDROME 2 0.0062
24 IMMUNODEFICIENCY COMMON VARIABLE 3 0.0061
25 LENTIGO 3 0.0060
26 RESPIRATORY TRACT INFECTION BACTERIAL 3 0.0060
27 DEVICE INFUSION ISSUE 14 0.0056
28 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 30 0.0055
29 BRONCHITIS CHRONIC 13 0.0053
30 PRE-EXISTING CONDITION IMPROVED 33 0.0053
31 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 7 0.0052
32 POST-ACUTE COVID-19 SYNDROME 6 0.0048
33 MEDICAL DEVICE SITE INFECTION 3 0.0048
34 CORNEAL DYSTROPHY 2 0.0048
35 MITRAL VALVE CALCIFICATION 3 0.0047
36 ENTEROVIRUS INFECTION 4 0.0046
37 INFUSION SITE HAEMORRHAGE 15 0.0046
38 INFUSION SITE PRURITUS 14 0.0044
39 THERAPEUTIC PRODUCT INEFFECTIVE 17 0.0044
40 MITRAL VALVE PROLAPSE 7 0.0042
41 ORTHOSTATIC INTOLERANCE 3 0.0042
42 VITAMIN B COMPLEX DEFICIENCY 3 0.0040
43 MEDICAL DEVICE IMPLANTATION 6 0.0038
44 SINUSITIS BACTERIAL 4 0.0038
45 OXYGEN CONSUMPTION INCREASED 9 0.0038
46 PRODUCT ADMINISTRATION INTERRUPTED 29 0.0037
47 INFUSION SITE MASS 4 0.0037
48 UTERINE PROLAPSE 4 0.0037
49 INFUSION SITE RASH 5 0.0036
50 MAST CELL ACTIVATION SYNDROME 5 0.0036
51 INCORRECT DOSE ADMINISTERED BY DEVICE 90 0.0034
52 CYSTIC FIBROSIS 19 0.0034
53 ADENOMYOSIS 2 0.0034
54 INFUSION SITE SWELLING 21 0.0033
55 BLOOD MAGNESIUM INCREASED 3 0.0033
56 INFUSION SITE WARMTH 4 0.0033
57 GESTATIONAL HYPERTENSION 4 0.0031
58 ANIMAL SCRATCH 3 0.0031
59 MULTIPLE ALLERGIES 23 0.0029
60 NASAL DISCHARGE DISCOLOURATION 4 0.0029
61 VASCULAR CALCIFICATION 3 0.0028
62 NO ADVERSE EVENT 510 0.0028
63 EXPOSURE TO TOXIC AGENT 9 0.0028
64 NOROVIRUS INFECTION 4 0.0028
65 MIDDLE EAR EFFUSION 6 0.0027
66 SEASONAL ALLERGY 38 0.0027
67 CHRONIC SINUSITIS 10 0.0027
68 BENIGN NEOPLASM 3 0.0027
69 RUBBER SENSITIVITY 4 0.0026
70 MYCOBACTERIUM AVIUM COMPLEX INFECTION 7 0.0026
71 RHINOVIRUS INFECTION 10 0.0026
72 NASAL SEPTUM DEVIATION 5 0.0026
73 DEVICE DISPENSING ERROR 3 0.0025
74 CROUP INFECTIOUS 2 0.0025
75 SCOLIOSIS 15 0.0024
76 ATRIAL TACHYCARDIA 5 0.0024
77 INFUSION SITE ERYTHEMA 20 0.0024
78 INFUSION SITE IRRITATION 3 0.0023
79 CRANIOFACIAL FRACTURE 2 0.0023
80 INFUSION SITE PAIN 30 0.0023
81 CYSTOCELE 2 0.0023
82 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
83 PRODUCT LOT NUMBER ISSUE 5 0.0023
84 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
85 BLOOD LOSS ANAEMIA 5 0.0022
86 CARBON DIOXIDE INCREASED 3 0.0022
87 CATHETER SITE SWELLING 2 0.0021
88 CATAPLEXY 3 0.0021
89 PSEUDOMONAS INFECTION 18 0.0021
90 VASCULAR INJURY 3 0.0021
91 RESPIRATORY TRACT INFECTION 54 0.0021
92 BLOOD IMMUNOGLOBULIN E INCREASED 5 0.0021
93 CONJUNCTIVITIS ALLERGIC 3 0.0020
94 TRIGGER FINGER 8 0.0020
95 PNEUMONIA PSEUDOMONAL 3 0.0020
96 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
97 AORTIC ARTERIOSCLEROSIS 5 0.0019
98 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
99 ROSACEA 9 0.0019
100 BURNS THIRD DEGREE 2 0.0019
101 CYSTITIS INTERSTITIAL 3 0.0019
102 ASTHMA 210 0.0019
103 CLAUSTROPHOBIA 2 0.0018
104 PULMONARY FUNCTION TEST DECREASED 8 0.0018
105 FOOD ALLERGY 14 0.0018
106 SALMONELLOSIS 3 0.0018
107 EAR INFECTION 47 0.0018
108 LOWER RESPIRATORY TRACT CONGESTION 3 0.0018
109 HAEMATOCRIT INCREASED 4 0.0018
110 HAEMOGLOBIN INCREASED 8 0.0018
111 OBSTRUCTION 7 0.0018
112 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
113 VOCAL CORD PARALYSIS 3 0.0017
114 CHRONIC RESPIRATORY FAILURE 2 0.0017
115 OESOPHAGEAL SPASM 3 0.0016
116 BLOOD UREA DECREASED 2 0.0016
117 NARCOLEPSY 3 0.0016
118 PARANASAL SINUS DISCOMFORT 6 0.0016
119 RHINITIS ALLERGIC 7 0.0016
120 ABDOMINAL WALL HAEMATOMA 3 0.0015
121 SOMNAMBULISM 10 0.0015
122 VOCAL CORD DISORDER 3 0.0015
123 ATRIAL FLUTTER 12 0.0015
124 ANIMAL BITE 4 0.0015
125 FOOD POISONING 8 0.0015
126 DERMATITIS CONTACT 17 0.0015
127 ENURESIS 6 0.0015
128 SINUSITIS 152 0.0015
129 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
130 SLEEP APNOEA SYNDROME 28 0.0015
131 RENAL MASS 3 0.0015
132 HYPERPARATHYROIDISM 3 0.0015
133 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
134 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
135 CONNECTIVE TISSUE DISORDER 2 0.0014
136 SKIN WEEPING 5 0.0014
137 EMPHYSEMA 14 0.0014
138 HORDEOLUM 6 0.0014
139 PHARYNGITIS STREPTOCOCCAL 15 0.0014
140 GASTRIC BYPASS 3 0.0014
141 SPONDYLITIS 5 0.0014
142 BRONCHITIS 101 0.0014
143 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
144 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
145 INFUSION SITE REACTION 4 0.0013
146 INFECTIOUS MONONUCLEOSIS 3 0.0013
147 BRONCHIECTASIS 9 0.0013
148 IRON DEFICIENCY 6 0.0013
149 VITAMIN D DEFICIENCY 13 0.0013
150 PNEUMONIA BACTERIAL 12 0.0013
151 INFUSION SITE INFECTION 3 0.0013
152 ORAL SURGERY 3 0.0013
153 SKIN ABRASION 6 0.0013
154 DIVERTICULUM 9 0.0013
155 SINUS OPERATION 3 0.0013
156 URINARY HESITATION 3 0.0013
157 PNEUMONIA VIRAL 4 0.0013
158 CEREBRAL ATROPHY 5 0.0013
159 SKIN PAPILLOMA 5 0.0012
160 DERMAL CYST 3 0.0012
161 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
162 INSURANCE ISSUE 18 0.0012
163 DEAFNESS BILATERAL 2 0.0012
164 RESPIRATION ABNORMAL 8 0.0012
165 SKIN INFECTION 13 0.0012
166 INJECTION SITE VESICLES 7 0.0012
167 CATHETER SITE PAIN 3 0.0012
168 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
169 ALOPECIA AREATA 2 0.0011
170 RADICULOPATHY 3 0.0011
171 NASAL DISORDER 3 0.0011
172 PRODUCT DELIVERY MECHANISM ISSUE 6 0.0011
173 SINUS DISORDER 22 0.0011
174 GASTROENTERITIS VIRAL 20 0.0011
175 EAR CONGESTION 3 0.0011
176 INVASIVE DUCTAL BREAST CARCINOMA 3 0.0011
177 PRODUCTIVE COUGH 52 0.0011
178 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
179 PRODUCT DISTRIBUTION ISSUE 10 0.0011
180 RESPIRATORY TRACT CONGESTION 17 0.0011
181 OXYGEN SATURATION ABNORMAL 3 0.0011
182 ADRENAL DISORDER 2 0.0010
183 FIBULA FRACTURE 3 0.0010
184 SECRETION DISCHARGE 13 0.0010
185 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
186 CONCUSSION 8 0.0010
187 DIZZINESS POSTURAL 10 0.0010
188 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
189 HEREDITARY ANGIOEDEMA 11 0.0010
190 BRAIN FOG 16 0.0010
191 STRIDOR 3 0.0010
192 NASAL POLYPS 5 0.0010
193 CREPITATIONS 3 0.0010
194 CANDIDA INFECTION 17 0.0010
195 URINE ANALYSIS ABNORMAL 3 0.0010
196 ATYPICAL PNEUMONIA 3 0.0010
197 METABOLIC ENCEPHALOPATHY 3 0.0010
198 CENTRAL VENOUS CATHETERISATION 3 0.0010
199 VIRAL INFECTION 33 0.0010
200 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
201 VITAMIN B12 DEFICIENCY 4 0.0010
202 IRITIS 3 0.0010
203 BRONCHOSPASM 14 0.0010
204 PERIPHERAL VENOUS DISEASE 4 0.0010
205 WHEEZING 58 0.0010
206 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 51 0.0010
207 GOITRE 4 0.0010
208 SPINAL STENOSIS 4 0.0010
209 CHEST INJURY 2 0.0010
210 THROAT TIGHTNESS 26 0.0010
211 BILE DUCT STONE 3 0.0009
212 INTERVERTEBRAL DISC DISORDER 4 0.0009
213 RESTLESS LEGS SYNDROME 17 0.0009
214 HAEMOPTYSIS 26 0.0009
215 INJECTION SITE DISCHARGE 5 0.0009
216 MUSCLE STRAIN 8 0.0009
217 WRIST FRACTURE 11 0.0009
218 PRODUCT PREPARATION ISSUE 6 0.0009
219 DEAFNESS NEUROSENSORY 3 0.0009
220 EXPIRED DEVICE USED 3 0.0009
221 PELVIC FRACTURE 7 0.0009
222 PLANTAR FASCIITIS 3 0.0009
223 ILLNESS 92 0.0009
224 GASTROINTESTINAL INFECTION 8 0.0009
225 ACUTE RESPIRATORY FAILURE 17 0.0009
226 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
227 HYPOPNOEA 3 0.0009
228 NEPHROGENIC ANAEMIA 4 0.0009
229 AORTIC STENOSIS 3 0.0009
230 BRONCHIOLITIS 3 0.0009
231 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
232 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
233 JOINT INJURY 18 0.0008
234 GASTROOESOPHAGEAL REFLUX DISEASE 67 0.0008
235 DYSPNOEA EXERTIONAL 31 0.0008
236 NASAL CONGESTION 48 0.0008
237 MENISCUS INJURY 5 0.0008
238 CARTILAGE INJURY 2 0.0008
239 ARTHROPOD BITE 6 0.0008
240 HYPERVOLAEMIA 4 0.0008
241 INFUSION SITE EXTRAVASATION 5 0.0008
242 OXYGEN SATURATION DECREASED 45 0.0008
243 SPINAL OSTEOARTHRITIS 7 0.0008
244 SNORING 3 0.0008
245 CATHETER SITE INFECTION 3 0.0008
246 PARANASAL SINUS HYPERSECRETION 3 0.0008
247 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
248 PRODUCT PREPARATION ERROR 16 0.0008
249 DYSPNOEA 440 0.0008
250 HIATUS HERNIA 10 0.0008
251 CHEST DISCOMFORT 79 0.0008
252 ACTINIC KERATOSIS 2 0.0008
253 MALABSORPTION 4 0.0008
254 WEIGHT FLUCTUATION 8 0.0008
255 COVID-19 PNEUMONIA 9 0.0008
256 PNEUMONIA FUNGAL 3 0.0008
257 COUGH 213 0.0008
258 RENAL CYST 6 0.0008
259 HYPERLIPIDAEMIA 9 0.0008
260 OESOPHAGEAL CANDIDIASIS 3 0.0008
261 ALCOHOL ABUSE 2 0.0007
262 ABDOMINAL MASS 2 0.0007
263 RHINITIS 6 0.0007
264 SQUAMOUS CELL CARCINOMA 7 0.0007
265 MYASTHENIA GRAVIS 6 0.0007
266 SINUS CONGESTION 10 0.0007
267 POST PROCEDURAL INFECTION 6 0.0007
268 PULMONARY THROMBOSIS 8 0.0007
269 SPINAL OPERATION 9 0.0007
270 CORONARY ARTERY OCCLUSION 10 0.0007
271 PHARYNGITIS 9 0.0007
272 INFLUENZA 80 0.0007
273 PHARYNGEAL SWELLING 7 0.0007
274 KIDNEY INFECTION 14 0.0007
275 DEVICE MALFUNCTION 50 0.0007
276 EYE INFECTION 8 0.0007
277 MUSCLE FATIGUE 3 0.0007
278 VITAMIN D DECREASED 6 0.0007
279 TENSION HEADACHE 3 0.0007
280 BACTERIAL INFECTION 13 0.0007
281 POOR QUALITY SLEEP 15 0.0007
282 IMPAIRED QUALITY OF LIFE 10 0.0007
283 MOUTH SWELLING 4 0.0007
284 MIGRAINE 66 0.0007
285 CHAPPED LIPS 3 0.0007
286 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
287 ONYCHOMYCOSIS 3 0.0007
288 OROPHARYNGEAL PAIN 63 0.0007
289 CATHETERISATION CARDIAC 3 0.0007
290 POOR VENOUS ACCESS 7 0.0007
291 HEART RATE INCREASED 67 0.0007
292 NEPHROLITHIASIS 31 0.0007
293 WHEELCHAIR USER 3 0.0007
294 ATAXIA 8 0.0007
295 PLEURISY 4 0.0007
296 PULMONARY HYPERTENSION 14 0.0007
297 MENINGITIS ASEPTIC 3 0.0007
298 ORAL HERPES 13 0.0007
299 PRODUCT TASTE ABNORMAL 9 0.0007
300 LOCALISED INFECTION 16 0.0007
301 VASCULAR DEVICE INFECTION 3 0.0007
302 CRANIOCEREBRAL INJURY 2 0.0007
303 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
304 INGUINAL HERNIA 4 0.0007
305 EYE OPERATION 3 0.0007
306 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
307 THROAT IRRITATION 29 0.0006
308 BACK INJURY 7 0.0006
309 GASTRITIS EROSIVE 3 0.0006
310 MUSCULOSKELETAL DISCOMFORT 11 0.0006
311 DEVICE DEFECTIVE 11 0.0006
312 SPUTUM DISCOLOURED 6 0.0006
313 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
314 LIMB INJURY 17 0.0006
315 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
316 CARDIAC FLUTTER 4 0.0006
317 HORMONE LEVEL ABNORMAL 3 0.0006
318 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
319 LUNG DISORDER 30 0.0006
320 COELIAC DISEASE 6 0.0006
321 ORAL CANDIDIASIS 8 0.0006
322 EXPIRED DRUG ADMINISTERED 3 0.0006
323 FOOT OPERATION 3 0.0006
324 DIABETIC NEUROPATHY 3 0.0006
325 PULMONARY MASS 9 0.0006
326 CONTUSION 58 0.0006
327 FLUID INTAKE REDUCED 3 0.0006
328 ANXIETY DISORDER 2 0.0006
329 OSTEOPENIA 9 0.0006
330 DRUG TOLERANCE 3 0.0006
331 EYE SWELLING 22 0.0006
332 CLOSTRIDIAL INFECTION 2 0.0006
333 HEPATIC STEATOSIS 11 0.0006
334 FLUID RETENTION 30 0.0006
335 RIB FRACTURE 12 0.0006
336 DRY EYE 29 0.0006
337 VARICOSE VEIN 3 0.0006
338 CERVICAL VERTEBRAL FRACTURE 2 0.0006
339 LUNG INFECTION 9 0.0006
340 ANAPHYLACTIC REACTION 32 0.0006
341 FEELING JITTERY 11 0.0006
342 COVID-19 101 0.0006
343 TRANSFUSION 6 0.0006
344 CARPAL TUNNEL SYNDROME 8 0.0006
345 SMALL INTESTINAL OBSTRUCTION 7 0.0006
346 DEVICE OCCLUSION 8 0.0006
347 PAPULE 4 0.0006
348 JOINT DISLOCATION 6 0.0006
349 OBESITY 9 0.0006
350 DYSPHONIA 33 0.0006
351 PALPITATIONS 66 0.0006
352 INTENTIONAL DOSE OMISSION 16 0.0006
353 OSTEOPOROSIS 23 0.0006
354 HYPERSOMNIA 16 0.0006
355 BRUXISM 3 0.0006
356 DECREASED ACTIVITY 6 0.0006
357 ANAL INCONTINENCE 5 0.0006
358 BONE LESION 2 0.0006
359 OROPHARYNGEAL DISCOMFORT 5 0.0006
360 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
361 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
362 JAW DISORDER 3 0.0005
363 STAPHYLOCOCCAL INFECTION 18 0.0005
364 ORAL DISORDER 4 0.0005
365 PHOTOSENSITIVITY REACTION 9 0.0005
366 DEAFNESS UNILATERAL 3 0.0005
367 CHOKING SENSATION 3 0.0005
368 HYPERKERATOSIS 3 0.0005
369 INCREASED TENDENCY TO BRUISE 5 0.0005
370 IRON DEFICIENCY ANAEMIA 5 0.0005
371 EXPIRED PRODUCT ADMINISTERED 18 0.0005
372 HYPOPHOSPHATAEMIA 4 0.0005
373 STREPTOCOCCAL INFECTION 3 0.0005
374 HEART RATE ABNORMAL 3 0.0005
375 RESPIRATORY DISORDER 16 0.0005
376 FIBROMYALGIA 13 0.0005
377 FLANK PAIN 5 0.0005
378 BLOOD POTASSIUM DECREASED 16 0.0005
379 PNEUMONIA 172 0.0005
380 PULMONARY CONGESTION 7 0.0005
381 PERIORBITAL SWELLING 3 0.0005
382 PERONEAL NERVE PALSY 3 0.0005
383 DEVICE ISSUE 47 0.0005
384 CLAVICLE FRACTURE 2 0.0005
385 EXERCISE TOLERANCE DECREASED 3 0.0005
386 DEVICE RELATED INFECTION 8 0.0005
387 DEVICE BREAKAGE 21 0.0005
388 MUSCULOSKELETAL CHEST PAIN 8 0.0005
389 EAR PAIN 10 0.0005
390 IMPAIRED GASTRIC EMPTYING 7 0.0005
391 CHRONIC KIDNEY DISEASE 39 0.0005
392 PULMONARY HAEMORRHAGE 4 0.0005
393 CYANOSIS 8 0.0005
394 HEAD DISCOMFORT 9 0.0005
395 LIGAMENT SPRAIN 5 0.0005
396 NASAL DISCOMFORT 4 0.0005
397 BLOOD PRESSURE ABNORMAL 10 0.0005
398 ACCIDENT 6 0.0005
399 ROAD TRAFFIC ACCIDENT 21 0.0005
400 GOUT 9 0.0005
401 BLEPHARITIS 2 0.0005
402 FRUSTRATION TOLERANCE DECREASED 4 0.0005
403 EPISTAXIS 37 0.0005
404 NOCTURIA 6 0.0005
405 INJECTION SITE URTICARIA 12 0.0005
406 CARDIOMEGALY 6 0.0005
407 PARAESTHESIA ORAL 7 0.0005
408 AORTIC DISSECTION 2 0.0005
409 NASOPHARYNGITIS 89 0.0005
410 TENDERNESS 5 0.0005
411 FOOT FRACTURE 9 0.0005
412 GASTRIC ULCER 9 0.0005
413 INCONTINENCE 5 0.0005
414 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
415 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
416 RESPIRATORY DISTRESS 13 0.0005
417 SCREAMING 3 0.0005
418 EATING DISORDER 10 0.0005
419 BODY HEIGHT DECREASED 5 0.0005
420 SCAR 8 0.0005
421 IRRITABLE BOWEL SYNDROME 10 0.0005
422 HERNIA 9 0.0005
423 ABNORMAL SENSATION IN EYE 2 0.0005
424 CHOKING 9 0.0005
425 EYE PAIN 26 0.0005
426 SURGERY 27 0.0005
427 SKIN FISSURES 9 0.0005
428 SKIN LACERATION 5 0.0005
429 CELLULITIS 23 0.0005
430 WALKING AID USER 3 0.0005
431 SARS-COV-2 TEST POSITIVE 6 0.0005
432 HYPERSENSITIVITY 84 0.0005
433 HERPES ZOSTER 26 0.0005
434 LIMB DISCOMFORT 14 0.0005
435 CARDIAC FAILURE ACUTE 3 0.0004
436 POST-TRAUMATIC STRESS DISORDER 3 0.0004
437 OCULAR DISCOMFORT 5 0.0004
438 POSTOPERATIVE WOUND INFECTION 3 0.0004
439 HEART RATE IRREGULAR 10 0.0004
440 HEAD INJURY 14 0.0004
441 PRODUCT DOSE OMISSION ISSUE 130 0.0004
442 MITRAL VALVE INCOMPETENCE 5 0.0004
443 URINARY TRACT INFECTION 75 0.0004
444 CYSTITIS 14 0.0004
445 SCIATICA 7 0.0004
446 END STAGE RENAL DISEASE 8 0.0004
447 SCAB 5 0.0004
448 MICTURITION URGENCY 5 0.0004
449 CHOLECYSTECTOMY 5 0.0004
450 INTERNAL HAEMORRHAGE 5 0.0004
451 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
452 NEOPLASM 5 0.0004
453 DROOLING 3 0.0004
454 CHRONIC MYELOID LEUKAEMIA 2 0.0004
455 LARGE INTESTINE POLYP 3 0.0004
456 DIVERTICULITIS 12 0.0004
457 PERICARDIAL EFFUSION 10 0.0004
458 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
459 MUSCLE TIGHTNESS 7 0.0004
460 POLLAKIURIA 18 0.0004
461 APHONIA 6 0.0004
462 CORONARY ARTERY DISEASE 13 0.0004
463 NEPHROPATHY 4 0.0004
464 MIDDLE INSOMNIA 8 0.0004
465 EXPOSURE VIA SKIN CONTACT 11 0.0004
466 BLOOD SODIUM DECREASED 8 0.0004
467 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
468 HAND FRACTURE 3 0.0004
469 RETCHING 9 0.0004
470 PRODUCT SUPPLY ISSUE 3 0.0004
471 CATARACT 25 0.0004
472 GASTRITIS 11 0.0004
473 RHINORRHOEA 27 0.0004
474 PERICARDITIS 7 0.0004
475 TONGUE DISORDER 3 0.0004
476 INFECTION 60 0.0004
477 ATELECTASIS 4 0.0004
478 ERUCTATION 8 0.0004
479 GASTROINTESTINAL DISORDER 37 0.0004
480 BLOOD PRESSURE INCREASED 63 0.0004
481 AUTOIMMUNE DISORDER 4 0.0004
482 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
483 SENSITIVE SKIN 3 0.0004
484 BREATH SOUNDS ABNORMAL 2 0.0004
485 TENDON RUPTURE 5 0.0004
486 DEHYDRATION 54 0.0004
487 SKIN HAEMORRHAGE 6 0.0004
488 IMMUNODEFICIENCY 6 0.0004
489 ANEURYSM 2 0.0004
490 DEVICE USE ISSUE 7 0.0004
491 WEIGHT DECREASED 111 0.0004
492 ECONOMIC PROBLEM 6 0.0004
493 CORONARY ARTERIAL STENT INSERTION 2 0.0004
494 DEVICE FAILURE 6 0.0004
495 PROCEDURAL COMPLICATION 3 0.0004
496 EAR DISCOMFORT 4 0.0004
497 HEADACHE 244 0.0004
498 PAIN IN JAW 11 0.0004
499 ANKLE FRACTURE 6 0.0004
500 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
501 EYE PRURITUS 13 0.0004
502 PETECHIAE 4 0.0004
503 NERVOUSNESS 20 0.0004
504 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
505 ECZEMA 20 0.0004
506 KNEE ARTHROPLASTY 8 0.0004
507 IMMUNE SYSTEM DISORDER 5 0.0004
508 ANKYLOSING SPONDYLITIS 5 0.0004
509 TOOTH INFECTION 5 0.0004
510 FURUNCLE 3 0.0004
511 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 68 0.0004
512 NIGHTMARE 13 0.0004
513 COMPRESSION FRACTURE 2 0.0004
514 SYNCOPE 37 0.0004
515 BEHAVIOUR DISORDER 2 0.0004
516 BLOOD POTASSIUM INCREASED 6 0.0004
517 BACK DISORDER 6 0.0004
518 ARTHRITIS 29 0.0004
519 BIPOLAR DISORDER 4 0.0004
520 ASPIRATION 4 0.0004
521 PULMONARY FIBROSIS 7 0.0004
522 ESCHERICHIA INFECTION 3 0.0004
523 GASTROINTESTINAL PAIN 4 0.0004
524 PRODUCT USE IN UNAPPROVED INDICATION 90 0.0004
525 MENSTRUAL DISORDER 3 0.0004
526 BLOOD PRESSURE DECREASED 24 0.0004
527 PNEUMONIA ASPIRATION 9 0.0004
528 EOSINOPHIL COUNT INCREASED 3 0.0004
529 BALANCE DISORDER 31 0.0004
530 INJECTION SITE RASH 11 0.0004
531 SNEEZING 8 0.0004
532 PANIC ATTACK 13 0.0004
533 RESPIRATORY FAILURE 26 0.0004
534 CHOLECYSTITIS ACUTE 2 0.0004
535 UPPER LIMB FRACTURE 7 0.0004
536 CARDIAC VALVE DISEASE 2 0.0003
537 ATRIAL FIBRILLATION 34 0.0003
538 DIZZINESS 174 0.0003
539 PARANOIA 6 0.0003
540 GASTRIC HAEMORRHAGE 4 0.0003
541 BLOOD MAGNESIUM DECREASED 3 0.0003
542 HYSTERECTOMY 3 0.0003
543 DEVICE LEAKAGE 15 0.0003
544 CHEST PAIN 64 0.0003
545 ORTHOSTATIC HYPOTENSION 6 0.0003
546 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
547 BLOOD CHOLESTEROL INCREASED 16 0.0003
548 HIP FRACTURE 11 0.0003
549 HEART RATE DECREASED 12 0.0003
550 HYPERHIDROSIS 44 0.0003
551 INJECTION SITE SWELLING 26 0.0003
552 BLOOD IRON DECREASED 4 0.0003
553 FALL 112 0.0003
554 FEAR 9 0.0003
555 INFUSION RELATED REACTION 22 0.0003
556 TOOTHACHE 6 0.0003
557 TREMOR 55 0.0003
558 PERIPHERAL SWELLING 51 0.0003
559 OSTEOARTHRITIS 14 0.0003
560 BURSITIS 4 0.0003
561 PRESYNCOPE 8 0.0003
562 NEURALGIA 8 0.0003
563 URTICARIA 55 0.0003
564 DYSURIA 12 0.0003
565 NERVE COMPRESSION 3 0.0003
566 HYPOKALAEMIA 15 0.0003
567 FLUSHING 33 0.0003
568 THYROID DISORDER 5 0.0003
569 ARTHROPATHY 18 0.0003
570 GENERALISED OEDEMA 4 0.0003
571 TENDONITIS 5 0.0003
572 NECK PAIN 18 0.0003
573 THINKING ABNORMAL 6 0.0003
574 MENTAL DISORDER 14 0.0003
575 TOOTH EXTRACTION 4 0.0003
576 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
577 DIARRHOEA HAEMORRHAGIC 3 0.0003
578 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
579 DRY MOUTH 26 0.0003
580 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
581 BACK PAIN 74 0.0003
582 MALAISE 139 0.0003
583 SPINAL DISORDER 3 0.0003
584 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
585 PNEUMOTHORAX 5 0.0003
586 ULCER 5 0.0003
587 POST PROCEDURAL COMPLICATION 6 0.0003
588 HYPOXIA 11 0.0003
589 LOWER LIMB FRACTURE 6 0.0003
590 CARDIAC FAILURE CONGESTIVE 25 0.0003
591 FEELING ABNORMAL 74 0.0003
592 INFLAMMATORY BOWEL DISEASE 3 0.0003
593 ASPERGILLUS INFECTION 2 0.0003
594 URINARY INCONTINENCE 9 0.0003
595 INFLUENZA LIKE ILLNESS 25 0.0003
596 MUSCLE TWITCHING 7 0.0003
597 HAEMATOCRIT DECREASED 6 0.0003
598 BLADDER DISORDER 3 0.0003
599 INABILITY TO AFFORD MEDICATION 3 0.0003
600 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
601 ANXIETY 85 0.0003
602 INJECTION SITE PRURITUS 20 0.0003
603 ABDOMINAL DISCOMFORT 50 0.0003
604 BREAST MASS 2 0.0003
605 SLEEP DISORDER 21 0.0003
606 COLITIS ISCHAEMIC 2 0.0003
607 EYE IRRITATION 17 0.0003
608 VERTIGO 18 0.0003
609 PRODUCT SUBSTITUTION ISSUE 17 0.0003
610 PRODUCT PRESCRIBING ERROR 7 0.0003
611 NEUTROPHIL COUNT INCREASED 3 0.0003
612 HOSPITALISATION 45 0.0003
613 INTESTINAL OBSTRUCTION 11 0.0003
614 TEMPERATURE INTOLERANCE 3 0.0003
615 NAUSEA 229 0.0003
616 THERAPY NON-RESPONDER 13 0.0003
617 FATIGUE 225 0.0003
618 HUNGER 4 0.0003
619 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
620 PRODUCT ODOUR ABNORMAL 3 0.0003
621 WEIGHT INCREASED 64 0.0003
622 DEFAECATION URGENCY 2 0.0003
623 INJECTION SITE DISCOMFORT 3 0.0003
624 DERMATITIS ATOPIC 15 0.0003
625 ABASIA 7 0.0003
626 RENAL PAIN 3 0.0003
627 HYPOTHYROIDISM 9 0.0003
628 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
629 TACHYCARDIA 25 0.0003
630 RED BLOOD CELL COUNT DECREASED 8 0.0003
631 CONSTIPATION 61 0.0003
632 PLEURAL EFFUSION 17 0.0003
633 NIGHT SWEATS 9 0.0003
634 HYPERTENSION 59 0.0003
635 MUSCLE SPASMS 51 0.0003
636 CARDIAC DISORDER 26 0.0003
637 VOMITING 130 0.0003
638 HAEMATEMESIS 7 0.0003
639 ARRHYTHMIA 13 0.0003
640 HYPOTENSION 55 0.0003
641 OCULAR HYPERAEMIA 13 0.0003
642 TOOTH FRACTURE 3 0.0003
643 FOOT DEFORMITY 3 0.0003
644 INSOMNIA 72 0.0003
645 LIP SWELLING 9 0.0003
646 HAEMATOMA 7 0.0003
647 FUNGAL INFECTION 9 0.0003
648 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
649 NERVE INJURY 3 0.0003
650 MALNUTRITION 3 0.0003
651 RASH PAPULAR 6 0.0003
652 SPEECH DISORDER 14 0.0003
653 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 54 0.0003
654 ANGER 9 0.0003
655 PRURITUS 102 0.0003
656 HYPOAESTHESIA ORAL 4 0.0003
657 LACRIMATION INCREASED 8 0.0003
658 UNEVALUABLE EVENT 20 0.0003
659 DYSPEPSIA 26 0.0003
660 DEPRESSION 60 0.0003
661 INJECTION SITE BRUISING 21 0.0003
662 PROTEINURIA 5 0.0003
663 AORTIC ANEURYSM 2 0.0003
664 SUICIDAL IDEATION 24 0.0003
665 TINNITUS 12 0.0003
666 BOWEL MOVEMENT IRREGULARITY 2 0.0003
667 LETHARGY 15 0.0003
668 EMOTIONAL DISORDER 8 0.0003
669 ATRIOVENTRICULAR BLOCK 2 0.0003
670 ELECTROLYTE IMBALANCE 3 0.0003
671 RASH MACULAR 9 0.0003
672 CONDITION AGGRAVATED 78 0.0003
673 HAEMORRHOIDS 5 0.0003
674 SPINAL PAIN 3 0.0003
675 OEDEMA PERIPHERAL 31 0.0003
676 PRODUCT USE COMPLAINT 4 0.0003
677 HAEMOGLOBIN DECREASED 26 0.0003
678 PROCEDURAL PAIN 7 0.0003
679 NEUROPATHY PERIPHERAL 24 0.0003
680 BLOOD ALBUMIN DECREASED 2 0.0003
681 THERAPY INTERRUPTED 18 0.0003
682 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
683 MACULAR DEGENERATION 3 0.0003
684 MOOD SWINGS 8 0.0003
685 ARTHRALGIA 104 0.0002
686 ADVERSE EVENT 23 0.0002
687 THROMBOSIS 20 0.0002
688 DRUG INTOLERANCE 24 0.0002
689 DEEP VEIN THROMBOSIS 16 0.0002
690 NO THERAPEUTIC RESPONSE 3 0.0002
691 RESTLESSNESS 9 0.0002
692 PULMONARY OEDEMA 11 0.0002
693 RESPIRATORY DEPRESSION 3 0.0002
694 MUSCLE SPASTICITY 3 0.0002
695 ABNORMAL FAECES 2 0.0002
696 INJECTION SITE MASS 9 0.0002
697 EYE DISORDER 8 0.0002
698 PYREXIA 84 0.0002
699 VENTRICULAR TACHYCARDIA 4 0.0002
700 ACUTE CORONARY SYNDROME 2 0.0002
701 RENAL FAILURE 32 0.0002
702 AGEUSIA 6 0.0002
703 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
704 TYPE 2 DIABETES MELLITUS 8 0.0002
705 PAIN IN EXTREMITY 70 0.0002
706 DIARRHOEA 153 0.0002
707 CARDIAC FAILURE 19 0.0002
708 RENAL DISORDER 11 0.0002
709 RENAL INJURY 7 0.0002
710 SWELLING 22 0.0002
711 SKIN CANCER 5 0.0002
712 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
713 SWELLING FACE 15 0.0002
714 NODULE 3 0.0002
715 PRODUCT PRESCRIBING ISSUE 5 0.0002
716 RASH 100 0.0002
717 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
718 MUSCULAR WEAKNESS 26 0.0002
719 SYRINGE ISSUE 4 0.0002
720 INCORRECT PRODUCT STORAGE 3 0.0002
721 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
722 PAIN 139 0.0002
723 ADVERSE REACTION 3 0.0002
724 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
725 SEIZURE 26 0.0002
726 OFF LABEL USE 197 0.0002
727 INJECTION SITE PAIN 69 0.0002
728 TOOTH DISORDER 5 0.0002
729 HAIR TEXTURE ABNORMAL 3 0.0002
730 SOMNOLENCE 45 0.0002
731 ORAL PAIN 5 0.0002
732 CHROMATURIA 5 0.0002
733 LEUKOCYTOSIS 4 0.0002
734 OSTEOMYELITIS 4 0.0002
735 CRYING 8 0.0002
736 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
737 DEVICE MECHANICAL ISSUE 3 0.0002
738 LOSS OF CONSCIOUSNESS 28 0.0002
739 VISION BLURRED 30 0.0002
740 PERIPHERAL COLDNESS 3 0.0002
741 ASTHENIA 82 0.0002
742 SKIN DISCOLOURATION 10 0.0002
743 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
744 INTENTIONAL PRODUCT MISUSE 19 0.0002
745 BLOOD GLUCOSE ABNORMAL 4 0.0002
746 HYPOMAGNESAEMIA 3 0.0002
747 COORDINATION ABNORMAL 3 0.0002
748 INCORRECT DOSE ADMINISTERED 49 0.0002
749 APPENDICITIS 2 0.0002
750 PRODUCT QUALITY ISSUE 29 0.0002
751 CHOLELITHIASIS 7 0.0002
752 INJECTION SITE HAEMORRHAGE 17 0.0002
753 PHOTOPHOBIA 4 0.0002
754 FEELING HOT 13 0.0002
755 DIALYSIS 3 0.0002
756 RHEUMATOID ARTHRITIS 24 0.0002
757 SINUS TACHYCARDIA 3 0.0002
758 ABDOMINAL DISTENSION 22 0.0002
759 ABDOMINAL PAIN 49 0.0002
760 URINARY RETENTION 7 0.0002
761 PARALYSIS 3 0.0002
762 ANGINA PECTORIS 6 0.0002
763 INCREASED APPETITE 4 0.0002
764 BLOOD PRESSURE FLUCTUATION 5 0.0002
765 GLAUCOMA 4 0.0002
766 BRADYCARDIA 11 0.0002
767 HYPERTHYROIDISM 3 0.0002
768 INJECTION SITE HAEMATOMA 3 0.0002
769 DECREASED APPETITE 48 0.0002
770 HYPOKINESIA 3 0.0002
771 FLUID OVERLOAD 3 0.0002
772 NEEDLE ISSUE 6 0.0002
773 MYALGIA 35 0.0002
774 GASTROENTERITIS 3 0.0002
775 GASTRIC DISORDER 7 0.0002
776 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
777 BODY TEMPERATURE DECREASED 2 0.0002
778 RASH PRURITIC 11 0.0002
779 OEDEMA 11 0.0002
780 DISABILITY 4 0.0002
781 PRODUCT USE ISSUE 38 0.0002
782 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
783 DYSGEUSIA 15 0.0002
784 INJECTION SITE ERYTHEMA 25 0.0002
785 SKIN EXFOLIATION 17 0.0002
786 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
787 ANAEMIA 38 0.0002
788 HOT FLUSH 15 0.0002
789 PRODUCT PHYSICAL ISSUE 4 0.0002
790 LYMPHADENOPATHY 7 0.0002
791 FEEDING DISORDER 4 0.0002
792 DYSKINESIA 8 0.0002
793 DIABETES MELLITUS 15 0.0002
794 PHARYNGEAL OEDEMA 3 0.0002
795 DRY SKIN 26 0.0002
796 INJECTION SITE WARMTH 4 0.0002
797 EXPOSURE DURING PREGNANCY 12 0.0002
798 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
799 BASAL CELL CARCINOMA 3 0.0002
800 HEPATIC ENZYME INCREASED 13 0.0002
801 JOINT STIFFNESS 5 0.0002
802 DYSPHAGIA 18 0.0002
803 DEPRESSED MOOD 10 0.0002
804 BONE PAIN 11 0.0002
805 CHILLS 22 0.0002
806 BREAST PAIN 2 0.0002
807 BLOOD GLUCOSE DECREASED 9 0.0002
808 DRUG EFFECT DECREASED 10 0.0002
809 PRURITUS GENERALISED 4 0.0002
810 ABDOMINAL PAIN UPPER 38 0.0002
811 PALLOR 5 0.0002
812 PRODUCT DISPENSING ERROR 4 0.0002
813 PNEUMONITIS 5 0.0002
814 ACUTE KIDNEY INJURY 28 0.0002
815 TREATMENT NONCOMPLIANCE 10 0.0002
816 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
817 LIVER DISORDER 8 0.0002
818 ERYTHEMA 37 0.0002
819 FEELING COLD 5 0.0002
820 BLOOD UREA INCREASED 3 0.0002
821 BLOOD CALCIUM DECREASED 2 0.0002
822 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
823 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
824 ABNORMAL BEHAVIOUR 7 0.0002
825 PRODUCT AVAILABILITY ISSUE 4 0.0002
826 THERAPY CESSATION 9 0.0002
827 HAEMORRHAGE 18 0.0002
828 LOCAL SWELLING 3 0.0002
829 PARAESTHESIA 27 0.0002
830 BURNING SENSATION 12 0.0002
831 SEPSIS 19 0.0002
832 ACUTE MYOCARDIAL INFARCTION 5 0.0002
833 DRUG DOSE OMISSION 28 0.0002
834 GALLBLADDER DISORDER 3 0.0002
835 MEMORY IMPAIRMENT 23 0.0002
836 MULTIPLE SCLEROSIS 8 0.0002
837 GAIT DISTURBANCE 32 0.0002
838 HYPOAESTHESIA 25 0.0002
839 MOBILITY DECREASED 12 0.0002
840 ADVERSE DRUG REACTION 15 0.0002
841 PELVIC PAIN 3 0.0002
842 STOMATITIS 10 0.0002
843 DISCOMFORT 10 0.0002
844 ALOPECIA 32 0.0002
845 CONJUNCTIVITIS 3 0.0002
846 CYST 2 0.0002
847 SEPTIC SHOCK 7 0.0002
848 BLISTER 9 0.0002
849 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
850 HYPOCALCAEMIA 3 0.0002
851 BLOOD URINE PRESENT 3 0.0002
852 HYPOPHAGIA 4 0.0002
853 ERECTILE DYSFUNCTION 4 0.0002
854 MOVEMENT DISORDER 5 0.0002
855 PRESCRIBED OVERDOSE 3 0.0002
856 RASH GENERALISED 4 0.0002
857 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
858 IMPAIRED HEALING 5 0.0002
859 BEDRIDDEN 2 0.0002
860 DISORIENTATION 6 0.0002
861 PANCREATITIS 8 0.0002
862 DEVICE DIFFICULT TO USE 10 0.0002
863 AGITATION 11 0.0001
864 GAIT INABILITY 5 0.0001
865 FULL BLOOD COUNT DECREASED 3 0.0001
866 PAIN OF SKIN 4 0.0001
867 THERAPEUTIC RESPONSE DECREASED 9 0.0001
868 PRODUCT ADMINISTRATION ERROR 3 0.0001
869 MUSCULOSKELETAL STIFFNESS 13 0.0001
870 BODY TEMPERATURE INCREASED 3 0.0001
871 MOOD ALTERED 4 0.0001
872 ACUTE HEPATIC FAILURE 2 0.0001
873 HAEMATURIA 5 0.0001
874 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
875 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
876 INJECTION SITE REACTION 10 0.0001
877 TOOTH LOSS 3 0.0001
878 DERMATITIS 3 0.0001
879 WOUND 4 0.0001
880 HYPERKALAEMIA 5 0.0001
881 BLOOD TEST ABNORMAL 2 0.0001
882 CONFUSIONAL STATE 23 0.0001
883 FLATULENCE 8 0.0001
884 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
885 PRODUCT ADHESION ISSUE 5 0.0001
886 LIVER FUNCTION TEST INCREASED 3 0.0001
887 BREAST CANCER 13 0.0001
888 HYPOACUSIS 6 0.0001
889 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
890 VAGINAL HAEMORRHAGE 6 0.0001
891 ANOSMIA 2 0.0001
892 PRODUCT DOSE OMISSION 9 0.0001
893 INFLAMMATION 7 0.0001
894 COLON CANCER 2 0.0001
895 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
896 DYSARTHRIA 5 0.0001
897 HALLUCINATION 10 0.0001
898 BLOOD GLUCOSE INCREASED 25 0.0001
899 JOINT SWELLING 16 0.0001
900 ILL-DEFINED DISORDER 8 0.0001
901 SKIN IRRITATION 6 0.0001
902 DISTURBANCE IN ATTENTION 7 0.0001
903 FEMUR FRACTURE 4 0.0001
904 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
905 VISUAL IMPAIRMENT 16 0.0001
906 COGNITIVE DISORDER 6 0.0001
907 SWOLLEN TONGUE 4 0.0001
908 MYOCARDIAL INFARCTION 22 0.0001
909 DRUG INEFFECTIVE 166 0.0001
910 RASH ERYTHEMATOUS 6 0.0001
911 METABOLIC ACIDOSIS 4 0.0001
912 MENTAL IMPAIRMENT 3 0.0001
913 EXTRA DOSE ADMINISTERED 5 0.0001
914 PSORIATIC ARTHROPATHY 5 0.0001
915 LUNG NEOPLASM MALIGNANT 5 0.0001
916 VISUAL ACUITY REDUCED 4 0.0001
917 CYTOMEGALOVIRUS INFECTION 2 0.0001
918 AGGRESSION 6 0.0001
919 RENAL IMPAIRMENT 10 0.0001
920 ABDOMINAL PAIN LOWER 3 0.0001
921 RENAL FAILURE ACUTE 5 0.0001
922 IRRITABILITY 7 0.0001
923 RECTAL HAEMORRHAGE 5 0.0001
924 UNRESPONSIVE TO STIMULI 3 0.0001
925 EMOTIONAL DISTRESS 14 0.0001
926 DEAFNESS 3 0.0001
927 PRODUCT STORAGE ERROR 10 0.0001
928 ANHEDONIA 3 0.0001
929 FREQUENT BOWEL MOVEMENTS 3 0.0001
930 HYPERGLYCAEMIA 4 0.0001
931 BONE DISORDER 2 0.0001
932 RESPIRATORY ARREST 3 0.0001
933 HAEMATOCHEZIA 6 0.0001
934 AMNESIA 7 0.0001
935 PULMONARY EMBOLISM 10 0.0001
936 PANCREATIC CARCINOMA 3 0.0001
937 ASCITES 3 0.0001
938 PSYCHOTIC DISORDER 3 0.0001
939 APHASIA 3 0.0001
940 MUSCULOSKELETAL PAIN 5 0.0001
941 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
942 PLATELET COUNT DECREASED 10 0.0001
943 LACTIC ACIDOSIS 3 0.0001
944 DEVICE DISLOCATION 4 0.0001
945 BLOOD CREATININE INCREASED 6 0.0001
946 OSTEONECROSIS 3 0.0001
947 SKIN DISORDER 3 0.0001
948 NEOPLASM MALIGNANT 6 0.0001
949 HYPONATRAEMIA 5 0.0001
950 CEREBROVASCULAR ACCIDENT 15 0.0001
951 DEVICE USE ERROR 3 0.0001
952 INJURY 6 0.0001
953 COMA 4 0.0001
954 SKIN BURNING SENSATION 6 0.0001
955 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
956 DRUG EFFECT INCOMPLETE 3 0.0001
957 SUICIDE ATTEMPT 5 0.0001
958 COLITIS 3 0.0001
959 ACNE 6 0.0001
960 DEATH 66 0.0001
961 PSORIASIS 10 0.0001
962 BLOOD BILIRUBIN INCREASED 2 0.0001
963 NEUTROPHIL COUNT DECREASED 3 0.0001
964 ABNORMAL DREAMS 2 0.0001
965 CARDIO-RESPIRATORY ARREST 3 0.0001
966 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
967 ANGIOEDEMA 3 0.0001
968 DISEASE PROGRESSION 8 0.0001
969 COLITIS ULCERATIVE 3 0.0001
970 BONE DENSITY DECREASED 2 0.0001
971 DISEASE RECURRENCE 3 0.0001
972 INTERSTITIAL LUNG DISEASE 3 0.0001
973 HYPOGLYCAEMIA 3 0.0001
974 NEUTROPENIA 8 0.0001
975 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
976 DELIRIUM 2 0.0001
977 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
978 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
979 ABORTION SPONTANEOUS 2 0.0000
980 BLINDNESS 2 0.0000
981 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
982 DRUG INTERACTION 7 0.0000
983 OVERDOSE 9 0.0000
984 CARDIAC ARREST 3 0.0000
985 THROMBOCYTOPENIA 4 0.0000
986 TOXICITY TO VARIOUS AGENTS 6 0.0000
987 DRUG WITHDRAWAL SYNDROME 3 0.0000
988 MALIGNANT NEOPLASM PROGRESSION 3 0.0000